← Eichor
Study identifier: NCT07318727 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment

Condition: Endometrium Cancer  ·  Sponsor: Peking University People's Hospital

PhaseNA
Planned participants81
Who can joinFemale, 18 Years to 40 Years
Healthy volunteersNo

About this study

In this study, overweight and obese patients with endometrial cancer treated with fertility- sparing therapy were randomly divided into three groups. The first group was given Intermittent fasting, the second was given Low-energy balanced diet, the third group underwent routine care for self-weight management. Relevant information such as body morphology ,glycolipid metabolism and tumor outcomes of the subjects were collected. By evaluating the tumor outcome and changes in glycolipid metabolism indicators, to confirm the effectiveness and safety of diet interventions for overweight and obese patients with endometrial cancer and treatd with fertility preservation.

This description comes directly from the study's public registry record.

Talk to the study team

Li Xiaodan, Master  ·  15010305099  ·  lxd_2000_510@163.com

Yang Dandan  ·  18710217027  ·  yangdan951001@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Peking University People's HospitalBeijing, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07318727